We are live on
!
Find out more
BC
Broadwood Capital Portfolio holdings
AUM
$1.42B
1-Year Est. Return
34.72%
This Fund
S&P 500
This Quarter
Est. Return
+3.94%
1 Year Est. Return
+34.72%
3 Year Est. Return
+45.97%
5 Year Est. Return
+44.27%
10 Year Est. Return
+866.96%
AUM
$1.7B
AUM Growth
+$40.6M
(+2.4%)
Cap. Flow
+$39.7M
Cap. Flow
% of AUM
2.33%
Top 10 Holdings %
Top 10 Hldgs %
99.78%
Holding
13
New
1
Increased
1
Reduced
2
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
STAAR Surgical
STAA
|
+$38.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Monster Beverage
MNST
|
+$3.69M |
| 2 |
Serina Therapeutics
SER
|
+$116K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 36.93% |
| 2 | Healthcare | 30.27% |
| 3 | Industrials | 23.14% |
Similar funds
PTC
NI
CBA
KC
EWS
WC
IHG
SCM
Broadwood Capital's Q4 2025 Portfolio in Review
As of Q4 2025, Broadwood Capital held 13 positions worth $1.7B, up 2.4% from $1.66B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Broadwood Capital's Q4 2025 filing shows 1 new, 1 increased, 2 reduced and 1 closed positions. The largest sale was Monster Beverage, an estimated $3.69M.
By sector, the portfolio is most concentrated in Consumer Staples at 37% of assets, up from 33% a quarter earlier, followed by Healthcare and Industrials.
- Broadwood Capital added most to STAAR Surgical in Q4 2025, an estimated $38.7M increase.
- Broadwood Capital's biggest Q4 2025 reduction was Monster Beverage, cutting an estimated $3.69M.
- Broadwood Capital's ten largest holdings make up 100% of its $1.7B portfolio in Q4 2025.
- Broadwood Capital opened 1 new position and closed 1 in Q4 2025.
- Broadwood Capital's portfolio value rose 2.4% quarter-over-quarter to $1.7B.
Based on Broadwood Capital's 13F filing for Q4 2025, filed 17 Feb 2026.